HCV: Who Should We Screen and Why?

Slides:

Advertisements

Similar presentations

National Center for Chronic Disease Prevention and Health Promotion Division of Nutrition, Physical Activity, and Obesity Healthy Communities: Healthy.

Advertisements

Advances in the Treatment of Chronic Hepatitis C Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver.

Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,

HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.

Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:

Pennsylvania: The State of HCV 2015

AGING IN OREGON Understanding Long Term Care Services for the Older Adult Module 1 – Demographics and Definitions.

Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016.

Prevention of Perinatal and Childhood Hepatitis B Virus Infections Background on Where We’ve Been Lisa Jacques-Carroll, MSW Immunization Services Division,

Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

An Overview for Healthcare Providers

An Overview for Healthcare Providers

Multimodal Management of Opioid-Induced Constipation

is caused by the Hepatitis A virus (HAV)

Introduction to Direct-to-Consumer Genetic Testing

Hepatitis B and C management pathways in prison:

A qualitative assessment of factors impacting adoption and implementation of USPSTF age-based hepatitis C virus screening recommendations Amy B. Jessop,

Chronic HCV Infection and CKD

Talking to Patients About HCV Treatment

HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.

Chronic Hepatitis C Virus Infection

Dengue Prevention in Asia

Managing Women Living With HIV Infection

Starting Strong: Initial Evaluation of the Patient With HCV

Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D

Optimizing Therapy for Osteoarthritis

HCV Infection in the United States: What Are We Dealing With?

Expanding the Universe of Viral Hepatitis Treaters

Heart Rate, HF Admissions, and Readmissions

The Changing Therapeutic Landscape of CINV

Program Goals Overview of HIV Epidemic HIV and Communities of Color.

World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.

The HCV Revolution: Are You and Your Practice Ready?

HIV Management: An Update on the Latest EACS Guidelines

Stopping the Epidemic HIV Prevention Today

Number of HCV tests conducted

Best Practices in Screening and Linkage to Care in Hepatitis C Virus

RISK R isk of Perinatal and Early Childhood Infection

More Than Treatment.

ACIP Recommended Vaccines for Adults – By Age

HBV Infection: Some Sobering Facts

HBV Care Models: Community Collaborations for Best Practices

Evaluation of the Patient With HCV Infection

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

The State of Pneumococcal Disease Prevention

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.

The future of urate-lowering strategies for gout

Statins and HIV:.

Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018

What's New on Interventions for Lower Limb Spasticity?

Factor Xa Inhibitors in PAD

After the Baby Comes.

IBD Increases Risk for Vaccine-Preventable Diseases

Hepatitis C: After the Diagnosis

Managing Age-Related Clinical Issues in Hemophilia

A Guideline-Based Approach to HCV Care

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Assessing the Burden of Hyperkalemia

Managing Pain in the 21st Century

So Many Guidelines, So Little Time:

Assessing the Burden of Hyperkalemia

Removing Barriers in the HCV Cascade of Care

Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention.

NAFLD and NASH in Europe and Canada

Managing Hepatitis C in Vermont

Presentation transcript:

HCV: Who Should We Screen and Why?

Hepatitis C in the United States

All-Oral Therapies With Similar Efficacy for Chronic HCV Infection

Updates to HCV Screening Guidelines One-Time Screening for HCV Infection In Adults Born Between 1945 and 1965

HCV Cascade of Care

HCV: The Silent Epidemic Many Faces, No Voice

Burden of Disease

Who Should We Be Screening for HCV?

Who Else Should We Be Screening for HCV?

Why Baby Boomers?

Risk Factor-Based Screening Alone Did Not Work

Recommendations for the Identification of Chronic HCV Infection Among Persons Born During 1945 to 1965

Add Anti-HCV Reminder for Baby Boomers to Electronic Health Record

Summary It All Starts With Screening

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)